Sarah Tarbox-Berry, PhD

Lecturer; Licensed Clinical Psychologist

Research Departments & Organizations

Connecticut Mental Health Center

PRIME Psychosis Prodrome Research Clinic

Research Interests

Adolescent Development; Affective Disorders, Psychotic; Affective Symptoms; Behavioral Medicine; Behavioral Research; Child Development; Cognitive Therapy; Family Relations; Genetics, Behavioral; Mental Health; Neuropsychology; Paranoid Personality Disorder; Peer Group; Psychology, Clinical; Psychopathology; Resilience, Psychological; Schizoid Personality Disorder; Schizophrenia Spectrum and Other Psychotic Disorders; Schizotypal Personality Disorder; Social Adjustment; Social Isolation; Stress, Physiological; Stress, Psychological

Extensive Research Description

Dr. Tarbox has a long-standing commitment to research and treatment of schizophrenia and other psychotic disorders. The broad focus of her research is 1) identification of clinical-developmental markers of liability to schizophrenia, 2) examination of the biological/genetic basis of clinical antecedents in relation to schizophrenia epidemiology and pathophysiology, and 3) optimization of risk markers to advance risk prediction and screening, facilitate early detection of illness, and inform evidence-based intervention for young people at risk for schizophrenia.

Dr. Tarbox is especially interested in social functioning and developmental pathology of schizophrenia and the relation between social development, stress sensitivity, and risk/exacerbation of schizophrenia psychosis. Of the many schizophrenia pathologies, poor social functioning is an especially sensitive predictor of familial and non-familial vulnerability, contributes unique information to prediction of psychosis, and appears to be an important correlate of schizophrenia deveopmental pathology. Furthermore, interpersonal skills and social cognition may be key targets for treatment of youth at risk for schizophrenia.

Currently, Dr. Tarbox is conducting a family study to examine genetic correlation of social deficits and psychotic-like symptoms in young people at high-risk for psychosis and their discordant siblings, and in control sibling-pairs. Additional projects include an investigation of the relation between stressful or traumatic experiences in early childhood and contribution to risk for psychosis as well as a collaborative effort to identify genetic polymorphisms associated with onset of psychosis and develop an index of polymorphic risk for psychosis.

Clinical Trials

Conditions Study Title
Mental Health & Behavioral Research Randomized Controlled Trial of Aspirin vs Placebo in the Treatment of Pre-psychosis

Selected Publications

Edit this profile

Contact Info

Sarah Tarbox-Berry, PhD
Office Location
PRIME Prodromal Research ClinicConnecticut Mental Health Center
34 Park Street, Ste 38-D

New Haven, CT 06519
Mailing Address
PRIME Prodromal Research ClinicDept of Psychiatry, Yale School of Medicine, Connecticut Mental Health Center
34 Park Street

New Haven, CT 06159

Curriculum Vitae